May 13 2025
A new study published in Naunyn-Schmiedeberg’s Archives of Pharmacology found that cannabichromene (CBC), a non-psychoactive cannabinoid, may have significant antidepressant effects through its interaction with cannabinoid 2 (CB2) receptors. The study was conducted by researchers from four Indian institutions, including G D Goenka University and Amity University. Using a combination of computer modeling and animal …
May 12 2025
Hemp seed oil may offer a natural and effective alternative for wound care, outperforming conventional antibiotic ointments, according to new research published in the Narra J journal. Scientists from Universitas Syiah Kuala in Indonesia found that hemp seed oil significantly accelerated wound healing in mice compared to both untreated wounds and those treated with chloramphenicol, …
May 12 2025
A novel injectable implant delivering cannabidiol (CBD) directly to tumors has demonstrated promising results in slowing the progression of triple-negative breast cancer (TNBC), according to a study published in the International Journal of Pharmaceutics. Researchers at the University of Madrid developed an in situ forming implant (ISFI) designed to release CBD—a non-psychoactive component of cannabis—over …
May 08 2025
A study published recently from researchers at the University of Toronto and McMaster University finds that psilocybin, a psychedelic compound found in magic mushrooms, may safely reduce symptoms of depression in patients with Bipolar II disorder without triggering mania or psychosis. Published in the journal Psychedelic Medicine and epulbished by the U.S. National Library of …
May 08 2025
A newly published study has found that an oral cannabinoid formulation was more effective than the prescription drug pregabalin in alleviating chronic neuropathic pain in an animal model, while also reducing inflammation and oxidative stress. Researchers from Birla Institute of Technology and Science Pilani, Delhi Pharmaceutical Sciences & Research University, and the University of Delhi …
May 07 2025
Combining the cannabinoid cannabinol (CBN) with the breast cancer drug exemestane may significantly improve treatment outcomes for patients with estrogen receptor-positive (ER+) breast cancer, according to a new study published in the European Journal of Pharmacology. Researchers from Universidade do Porto in Portugal and the Technical University of Denmark evaluated the effects of CBN in …
May 06 2025
A study from researchers at the University of Birmingham found that a highly purified CBD isolate poses no genotoxic risk when tested using widely accepted toxicology standards. Published in the journal Pharmaceutical Biology, the study involved both a bacterial reverse mutation test (Ames test) and an in vitro mammalian cell micronucleus assay. These tests were …
May 06 2025
A large new study has found that marijuana use does not appear to harm semen quality in men of reproductive age. Published in the journal Andrology, the study analyzed 1,654 semen samples from 921 men participating in the Pregnancy Study Online (PRESTO), a North American cohort of couples trying to conceive. Researchers from Boston University, …
May 05 2025
A new study published in The American Journal of Medicine found that regular marijuana use is associated with reduced inflammation, but it does not appear to impact insulin sensitivity. Researchers at the University of Colorado studied healthy adults aged 21 to 40, comparing those who used marijuana at least weekly for a year to those …
May 04 2025
A new study from researchers at Qinghai University and the Tianjin University of Traditional Chinese Medicine found that a CBD-based hydrogel significantly improves healing in skin injuries caused by combined radiation and trauma, offering a promising new treatment for patients undergoing tumor surgery followed by radiotherapy. The study, published in Phytomedicine, tested various formulations of …
